Artelo Biosciences Statistics
Total Valuation
ARTL has a market cap or net worth of $7.76 million. The enterprise value is $7.84 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARTL has 736,127 shares outstanding. The number of shares has increased by 91.62% in one year.
| Current Share Class | 708,258 |
| Shares Outstanding | 736,127 |
| Shares Change (YoY) | +91.62% |
| Shares Change (QoQ) | +156.92% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 4.64% |
| Float | 705,074 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.17 |
Financial Efficiency
Return on equity (ROE) is -1,625.11% and return on invested capital (ROIC) is -602.24%.
| Return on Equity (ROE) | -1,625.11% |
| Return on Assets (ROA) | -190.09% |
| Return on Invested Capital (ROIC) | -602.24% |
| Return on Capital Employed (ROCE) | 917.46% |
| Weighted Average Cost of Capital (WACC) | 11.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.84M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.70% in the last 52 weeks. The beta is 1.07, so ARTL's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | -39.70% |
| 50-Day Moving Average | 4.67 |
| 200-Day Moving Average | 15.00 |
| Relative Strength Index (RSI) | 68.38 |
| Average Volume (20 Days) | 7,961,878 |
Short Selling Information
The latest short interest is 37,410, so 5.08% of the outstanding shares have been sold short.
| Short Interest | 37,410 |
| Short Previous Month | 53,146 |
| Short % of Shares Out | 5.08% |
| Short % of Float | 5.31% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.40M |
| Pretax Income | -12.88M |
| Net Income | -12.88M |
| EBITDA | n/a |
| EBIT | -11.40M |
| Earnings Per Share (EPS) | -$37.55 |
Full Income StatementBalance Sheet
The company has $600,000 in cash and $678,000 in debt, with a net cash position of -$78,000 or -$0.11 per share.
| Cash & Cash Equivalents | 600,000 |
| Total Debt | 678,000 |
| Net Cash | -78,000 |
| Net Cash Per Share | -$0.11 |
| Equity (Book Value) | -1.27M |
| Book Value Per Share | -1.89 |
| Working Capital | -3.35M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.52M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 584,000 |
| Free Cash Flow | -8.52M |
| FCF Per Share | -$11.57 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
